| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454892 | Lung Cancer | 2015 | 6 Pages |
Abstract
EBUS guided intratumoral cisplatin for IMHR appears to be safe and effective, and may represent a new treatment paradigm for this patient population.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hiren J. Mehta, Abbie Begnaud, Andrea M. Penley, John Wynne, Paras Malhotra, Sebastian Fernandez-Bussy, Jessica M. Cope, Jonathan J. Shuster, Michael A. Jantz,